Cleavage and polyadenylation-specific factor 3 induces cell cycle arrest via PI3K/Akt/GSK-3β signaling pathways and predicts a negative prognosis in hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Biomarkers in medicine"
DOI: 10.2217/bmm-2021-0039
Abstract: Background: Recent studies have shown that cleavage and polyadenylation-specific factor 3 (CPSF3) is a promising antitumor therapeutic target, but its potential role in hepatocellular carcinoma (HCC) has not been reported. Materials & methods: We explored… read more here.
Keywords: cleavage polyadenylation; hcc; group; specific factor ... See more keywords